Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections

Journal of Medical Microbiology

Volumn 60, Issue 3, 2011, Pages 300-306

  Bala, Anju ^a   Kumar, Ravi ^a   Harjai, Kusum ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BIOFILM; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; IN VITRO STUDY; MICROBIAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; SWIMMING; URINARY TRACT INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BIOFILMS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; KIDNEY; LOCOMOTION; MICE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUORUM SENSING; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 79951872404     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.025387-0     Document Type: Article

References (41)

1. Amsden, G. W. (2005). Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 55, 10-21.
2. Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D. & Buret, A. (1999). The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37, 1771-1776. (Pubitemid 29235221)
3. Costerton, J. W., Stewart, P. S. & Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322. (Pubitemid 29289651)
4. Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W. & Greenberg, E. P. (1998). The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280, 295-298.
5. de Kievit, T. R. (2009). Quorum sensing in Pseudomonas aeruginosa biofilms. Environ Microbiol 11, 279-288.
6. Donlan, R. M. (2001). Biofilms and device-associated infections. Emerg Infect Dis 7, 277-281.
7. Donlan, R. M. & Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167-193. (Pubitemid 34303762)
8. Ehrlich, G. D., Veeh, R., Wang, X., Costerton, J. W., Hayes, J. D., Hu, F. Z., Daigle, B. J., Ehrlich, M. D. & Post, J. C. (2002). Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA 287, 1710-1715. (Pubitemid 34289224)
9. Favre-Bonté, S., Köhler, T. & Van Delden, C. (2003). Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. J Antimicrob Chemother 52, 598-604. (Pubitemid 37258419)
10. Hansen, C. R., Pressler, T., Koch, C. & Høiby, N. (2005). Long-term azithromycin treatment of cystic fibrosis patients with chronic P. aeruginosa infection; an observational cohort study. J Cyst Fibros 4, 35-40. (Pubitemid 40347775)
11. Harjai, K., Khandwahaa, R. K., Mittal, R., Yadav, V., Gupta, V. & Sharma, S. (2005). Effect of pH on production of virulence factors by biofilm cells of P. aeruginosa. Folia Microbiol (Praha) 50, 99-102. (Pubitemid 41040505)
12. -/- mice. Antimicrob Agents Chemother 51, 3677-3687.
13. Ichimiya, T., Takeoka, K., Hiramatsu, K., Hirai, K., Yamasaki, T. & Nasu,M. (1996). The influence of azithromycin on the biofilmformation of Pseudomonas aeruginosa in vitro. Chemotherapy 42, 186-191. (Pubitemid 26095173)
14. Kakar, K., Sharma, S., Asnani, P. J., Banerjee, C. K. & Sharma, B. K. (1986). Experimental haematogenous pyelonephritis in mice with uropathogenic, enteropathogenic and enterotoxigenic Escherichia coli. Antonie van Leeuwenhoek 52, 153-161. (Pubitemid 17059333)
15. Köhler, T., Curty, L. K., Barja, F., van Delden, C. & Pechère, J.-C. (2000). Swarming of Pseudomonas aeruginosa is dependent on cell-tocell signaling and requires flagella and pili. J Bacteriol 182, 5990-5996.
16. Kumar, R., Chhibber, S. & Harjai, K. (2009). Quorum sensing is necessary for the virulence of Pseudomonas aeruginosa during urinary tract infection. Kidney Int 76, 286-292.
17. Mikuniya, T., Kato, Y., Kariyama, R., Monden, K., Hikida, M. & Kumon, H. (2005). Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm. Acta Med Okayama 59, 209-216. (Pubitemid 43143775)
18. Miller, J. H. (1972). Experiments in Molecular Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
19. Mittal, R., Chhibber, S., Sharma, S. & Harjai, K. (2006). Effect of macrophage secretory products on elaboration of virulence factors by planktonic and biofilm cells of Pseudomonas aeruginosa. Comp Immunol Microbiol Infect Dis 29, 12-26. (Pubitemid 43372684)
20. Molinari, G., Paglia, P. & Schito, G. C. (1992). Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin. Eur J Clin Microbiol Infect Dis 11, 469-471.
21. Moser, C., Jensen, P. O., Kobayashi, O., Shirai, R., Hougen, H. P. & Hoiby, N. (2002). Macrolide treatment improves outcome and reduces IL-4 production in susceptible Balb/C mice with chronic Pseudomonas aeruginosa lung infection. Pediatr Pulmonol Suppl 24, 275-280.
22. Nalca, Y., Jänsch, L., Bredenbruch, F., Geffers, R., Buer, J. & Häussler, S. (2006). Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob Agents Chemother 50, 1680-1688.
23. NCCLS (2002). Performance Standards for Antimicrobial Susceptibility Testing, 12th Informational Supplement. M100-S12. Wayne, PA: National Committee for Clinical Laboratory Standards.
24. Nicolau, D. P., Banevicius, M. A., Nightingale, C. H. & Quintiliani, R. (1999). Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model. Antimicrob Agents Chemother 43, 3033-3035.
25. O'Toole, G. A., Pratt, L. A., Watnick, P. I., Newman, D. K., Weaver, V. B. & Kolter, R. (1999). Genetic approaches to the study of biofilms. Methods Enzymol 310, 91-109.
26. Pechère, J. C. (2001). Azithromycin reduces the production of virulence factors in Pseudomonas aeruginosa by inhibiting quorum sensing. Jpn J Antibiot 54, 87-89.
27. Rashid, M. H. & Kornberg, A. (2000). Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 97, 4885-4890. (Pubitemid 30238652)
28. Rumbaugh, K. P., Griswold, J. A., Iglewski, B. H. & Hamood, A. N. (1999). Contribution of quorum sensing to the virulence of P. aeruginosa in burn wound infections. Infect Immun 67, 5854-5862. (Pubitemid 29508110)
29. Rumbaugh, K. P., Griswold, J. A. & Hamood, A. N. (2000). The role of quorum sensing in the in vivo virulence of Pseudomonas aeruginosa. Microbes Infect 2, 1721-1731.
30. Saiman, L., Chen, Y., Gabriel, P. S. & Knirsch, C. (2002). Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob Agents Chemother 46, 1105-1107. (Pubitemid 34260359)
31. Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J. & Greenberg, E. P. (2000). Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762-764.
32. Skindersoe, M. E., Alhede, M., Phipps, R., Yang, L., Jensen, P. O., Rasmussen, T. B., Bjarnsholt, T., Tolker-Nielsen, T., Høiby, N. & Givskov, M. (2008). Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 52, 3648-3663.
33. Smith, R. S., Harris, S. G., Phipps, R. & Iglewski, B. H. (2002). The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl) homoserine lactone contributes to virulence and induces inflammation in vivo. J Bacteriol 184, 1132-1139. (Pubitemid 34113382)
34. Sofer, D., Gilboa-Garber, N., Belz, A. & Garber, N. C. (1999). 'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. Chemotherapy 45, 335-341.
35. Tateda, K., Comte, R., Pechère, J. C., Köhler, T., Yamaguchi, K. & van Delden, C. (2001). Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45, 1930-1933. (Pubitemid 32466379)
36. Tsai, W. C., Rodriguez, M. L., Young, K. S., Deng, J. C., Thannickal, V. J., Tateda, K., Hershenson, M. B. & Standiford, T. J. (2004). Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. Am J Respir Crit Care Med 170, 1331-1339. (Pubitemid 39657198)
37. Van Delden, C. & Iglewski, B. H. (1998). Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 4, 551-560. (Pubitemid 28553680)
38. Venturi, V. (2006). Regulation of quorum sensing in Pseudomonas. FEMS Microbiol Rev 30, 274-291.
39. Wagner, V. E., Li, L.-L., Isabella, V. M. & Iglewski, B. H. (2007). Analysis of the hierarchy of quorum-sensing regulation in Pseudomonas aeruginosa. Anal Bioanal Chem 387, 469-479.
40. Willcox, M. D. P., Zhu, H., Conibear, T. C. R., Hume, E. B. H., Givskov, M., Kjelleberg, S. & Rice, S. A. (2008). Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis. Microbiology 154, 2184-2194.
41. Wolter, J. M. & McCormack, J. G. (1998). The effect of subinhibitory concentrations of antibiotics on adherence of Pseudomonas aeruginosa to cystic fibrosis (CF) and non-CF-affected tracheal epithelial cells. J Infect 37, 217-223. (Pubitemid 29017267)